ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DRMA Dermata Therapeutics Inc

0.4165
0.0234 (5.95%)
After Hours
Last Updated: 18:30:10
Delayed by 15 minutes

Period:

Draw Mode:

Volume 40,045
Bid Price 0.399
Ask Price 0.4165
News -
Day High 0.4165

Low
0.3701

52 Week Range

High
3.93

Day Low 0.395
Company Name Stock Ticker Symbol Market Type
Dermata Therapeutics Inc DRMA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0234 5.95% 0.4165 18:30:10
Open Price Low Price High Price Close Price Prev Close
0.3971 0.395 0.4165 0.4108 0.3931
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
79 40,045 $ 0.407013 $ 16,299 - 0.3701 - 3.93
Last Trade Time Type Quantity Stock Price Currency
17:15:21 formt 3,000 $ 0.4165 USD

Dermata Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.31M 3.19M - 0 -9.61M -3.01 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Dermata Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DRMA Message Board. Create One! See More Posts on DRMA Message Board See More Message Board Posts

Historical DRMA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.410.44260.38010.4046111112,9900.00651.59%
1 Month0.440.46240.37090.406030489,123-0.0235-5.34%
3 Months0.58250.890.37010.6171631851,164-0.166-28.50%
6 Months1.081.120.37010.638415511,313-0.6635-61.44%
1 Year1.323.930.37011.86897,925-0.9035-68.45%
3 Years92.80111.200.370110.01858,439-92.38-99.55%
5 Years92.80111.200.370110.01858,439-92.38-99.55%

Dermata Therapeutics Description

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

Your Recent History

Delayed Upgrade Clock